BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 22726924)

  • 1. Synthesis and biochemical evaluation of triazole/tetrazole-containing sulfonamides against thrombin and related serine proteases.
    Siles R; Kawasaki Y; Ross P; Freire E
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5305-9. PubMed ID: 21807511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma.
    Modrzycka S; Kołt S; Polderdijk SGI; Adams TE; Potoczek S; Huntington JA; Kasperkiewicz P; Drąg M
    Chem Sci; 2022 Jun; 13(23):6813-6829. PubMed ID: 35774156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma.
    Ma H; Hockla A; Mehner C; Coban M; Papo N; Radisky DC; Radisky ES
    Sci Rep; 2019 Feb; 9(1):1844. PubMed ID: 30755669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibitors of mesotrypsin from a structure-based docking screen.
    Kayode O; Huang Z; Soares AS; Caulfield TR; Dong Z; Bode AM; Radisky ES
    PLoS One; 2017; 12(5):e0176694. PubMed ID: 28463992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FeF(3) catalyzed cascade C-C and C-N bond formation: synthesis of differentially substituted triheterocyclic benzothiazole functionalities under solvent-free condition.
    Atar AB; Jeong YT
    Mol Divers; 2014 May; 18(2):389-401. PubMed ID: 24504377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy for a rational approach to designing synthetic selective inhibitors.
    Hijikata-Okunomiya A; Okamoto S
    Semin Thromb Hemost; 1992 Jan; 18(1):135-49. PubMed ID: 1574714
    [No Abstract]   [Full Text] [Related]  

  • 7. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
    Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
    Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.
    Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G
    J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
    De Simone G; Menchise V; Omaggio S; Pedone C; Scozzafava A; Supuran CT
    Biochemistry; 2003 Aug; 42(30):9013-21. PubMed ID: 12885234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
    Karle M; Knecht W; Xue Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition mechanism of trypsin by Schiff base metal chelate inhibitors].
    Iyaguchi D
    Yakugaku Zasshi; 2011; 131(9):1299-303. PubMed ID: 21881302
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.